Himalaya Nutravedics India Limited IPO Details

Factual IPO information from public filings. Not investment advice.

Issue Details

Price Band: ₹100 – ₹106
Lot Size: 1,200 shares
Min. Investment: ₹1,27,200
Total Issue Size: ₹26.5 Cr; 24,99,600 shares
Fresh Issue: ₹26.5 Cr; 24,99,600 shares
Offer for Sale: ₹0 Cr
Face Value: ₹10 per share
Issue Type: Book-built IPO
Listing At: BSE SME
Shares Pre-Issue: 63,06,720
Shares Post-Issue: 88,06,320

Lot Size & Investment

1 lot = 1,200 shares

Retail (min)

2 lots · 2,400 shares

Retail (max)

2 lots · 2,400 shares

S-HNI (min)

3 lots · 3,600 shares

Application	Lots	Shares	Amount
Retail	2	2,400	₹2,54,400
Small HNI (S-HNI)	3	3,600	₹3,81,600
Big HNI (B-HNI)	8	9,600	₹10,17,600

Financial Performance

Restated figures in ₹ crore, unless stated otherwise

Financial performance by period
Period	Mar-26	Mar-25	Mar-24
Assets	24.42	10.82	6.09
Total Income	43.12	21	14.43
Profit After Tax	7.39	2.23	0.43
EBITDA	8.1	2.99	0.94
Net Worth	16.38	6.75	1.34
Reserves & Surplus	10.07	2.76	0.53
Total Borrowing	5.13	1.76	3.24

Key Performance Indicators

Key performance indicators
Period	Mar-26
ROE (%)	63.87
ROCE (%)	36.41
EPS (₹)	11.72
P/E (pre-issue)	9.04
P/E (post-issue)	12.63

About Himalaya Nutravedics India Limited

Incorporated in June 2022, Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing and distribution of Ayurvedic and nutraceutical formulations in India and also undertakes third-party contract manufacturing for other Ayurvedic and nutraceutical companies. The Company manufactures a diversified portfolio comprising classical (Shastric) Ayurvedic formulations, proprietary Ayurvedic formulations and nutraceutical supplements. Its products are available in multiple dosage forms, including soft gelatin capsules, hard gelatin capsules, tablets, liquid orals and medicated oils. The products cater to therapeutic and wellness areas such as gut health, cardiac and metabolic wellness, diabetes management, pain management, immunity, women’s wellness and general wellness. Himalaya Nutravedics operates through a hybrid business model comprising its own branded products and third-party contract manufacturing. Under its own-brand business, the Company develops, manufactures and markets Ayurvedic and nutraceutical products, while its third-party manufacturing business provides formulation, manufacturing, packaging and dispatch services based on client specifications. As of March 31, 2026, its own-brand business contributed approximately ₹2,202.54 lakh, representing about 51.14% of total revenue. The Company operates an integrated manufacturing facility in Hyderabad, Telangana, where formulation, production, quality control, packaging and finished-goods release are carried out internally. The facility is compliant with WHO-GMP standards and holds registrations and licences from AYUSH and FSSAI, along with certifications including ISO 9001:2015, ISO 22000:2018, HACCP, HALAL and KOSHER. As of July 31, 2026, the Company had 86 full-time employees across marketing, factory, finance, quality, compliance and administration functions. Competitive Strengths Geographic expansion across India. Long-standing supplier and customer relationships. Integrated multi-dosage manufacturing capabilities. Doctor acceptance supported by product performance. Broad therapeutic coverage across Ayurvedic and nutraceutical segments